Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma

~6 mi. (Mount Kisco, New York, +61 more cities)

CareMount Medical Group

Classical Hodgkin Lymphoma

brentuximab vedotin, +5 more drugs

chemotherapy, +2 more types

To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313)

~14 mi. (Hawthorne, New York, +128 more cities)

Westchester Medical Center Advanced Oncology and Infusion Center

del(11)(q10), +27 more biomarkers

Myelofibrosis Transformation in Essential Thrombocythemia, +2 more conditions

parsaclisib, +1 more drug

targeted therapy

To Evaluate Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis Who Have Suboptimal Response to Ruxolitinib (LIMBER-304)

~14 mi. (Hawthorne, New York, +143 more cities)

Westchester Medical Center Advanced Oncology

del(11)(q10), +27 more biomarkers

Myelofibrosis

parsaclisib, +1 more drug

targeted therapy

A Study of BR Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreated MCL

~14 mi. (Hawthorne, New York, +118 more cities)

Research Site

CCND1-IGH Fusion, +2 more biomarkers

Mantle Cell Lymphoma

acalabrutinib, +2 more drugs

chemotherapy, +2 more types

Dociparstat (DSTAT) in Combination With Standard Chemotherapy for the Treatment of Acute Myeloid Leukemia (AML) (DASH AML)

~14 mi. (Hawthorne, New York, +13 more cities)

New York Medical College

ASXL1 Loss, +27 more biomarkers

Acute Myeloid Leukemia

chemotherapy, +1 more drug

chemotherapy, +1 more type

A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia

~15 mi. (Valhalla, New York, +173 more cities)

New York Medical College

B-Cell Lymphoblastic Leukemia/Lymphoma

asparaginase Erwinia chrysanthemi, +12 more drugs

chemotherapy, +2 more types

Active Surveillance, Bleomycin, Carboplatin, Etoposide, or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

~15 mi. (Valhalla, New York, +352 more cities)

Westchester Medical Center, +1 more facility

Immature Ovarian Teratoma, +2 more conditions

bleomycin, +3 more drugs

chemotherapy

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

~15 mi. (Valhalla, New York, +171 more cities)

New York Medical College

B-Cell Acute Lymphoblastic Leukemia, +2 more conditions

calaspargase pegol, +13 more drugs

chemotherapy, +2 more types

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

~15 mi. (Valhalla, New York, +146 more cities)

New York Medical College

BCR-ABL1 Fusion, +48 more biomarkers

Acute Myeloid Leukemia

allogeneic hematopoietic stem cell transplantation, +12 more drugs

cellular therapy, +4 more types

Nivolumab in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma

~15 mi. (Valhalla, New York, +104 more cities)

New York Medical College

Primary Mediastinal B-Cell Lymphoma

cyclophosphamide, +11 more drugs

chemotherapy, +4 more types

Iobenguane I-131 or Crizotinib and Standard Therapy in Treating Younger Patients With Newly-Diagnosed High-Risk Neuroblastoma or Ganglioneuroblastoma

~15 mi. (Valhalla, New York, +128 more cities)

New York Medical College

MYCN Amplification, +1 more biomarker

Ganglioneuroblastoma, +1 more condition

aldesleukin, +18 more drugs

cellular therapy, +4 more types

Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

~15 mi. (Valhalla, New York, +177 more cities)

New York Medical College

BCR-ABL1 Fusion, +1 more biomarker

Acute Lymphoblastic Leukemia

allogeneic hematopoietic stem cell transplantation, +18 more drugs

cellular therapy, +4 more types